CardioMEA:用于研究心脏病和药物反应的综合数据分析平台
Jihyun Lee1, Eliane Duperrex1, Ibrahim El-Battrawy2,3,4,5
1Department of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.
Frontiers in physiology
|November 14, 2024
概括
CardioMEA 是一个新的平台,用于分析来自人类诱导的多能干细胞干细胞衍生心肌细胞 (iPSC-CMs) 的高密度微电极阵列 (HD-MEA) 数据. 它通过分析细胞外和细胞内信号来帮助研究心脏病和药物效应.
科学领域:
- 生物医学工程 生物医学工程
- 心脏病学 心脏病学
- 干细胞生物学 干细胞生物学
背景情况:
- 高密度微电极阵列 (HD-MEAs) 对于研究心肌细胞电生理学至关重要.
- 现有的HD-MEA分析工具对于复杂的数据是不够的,特别是对于心律失常和药物测试研究.
- 人类诱导的多能干细胞衍生心肌细胞 (iPSC-CMs) 是临床前心脏研究的重要模型.
研究的目的:
- 开发一个全面的数据分析平台, CardioMEA,用于来自 iPSC-CMs 的 HD-MEA 数据.
- 为了实现电生理信号的可扩展处理和高级可视化.
- 为了促进对细胞外和细胞内信号的分析,以满足定制的研究需求.
主要方法:
- 介绍 CardioMEA,一个基于网络的平台,具有可扩展的数据处理管道.
- 开发模块,以区分患病与健康iPSC-CMs的电生理特征.
- 整合分析细胞外和细胞内信号的能力.
主要成果:
- 通过分析iPSC-CM对7种抗失常药物的反应,证明了CardioMEA的实用性.
- 展示了平台识别关键电生理学差异的能力.
- 验证了用于药物效应评估的两种信号类型的分析.
结论:
- 卡迪奥MEA提供了一个直观和用户友好的解决方案来分析HD-MEA数据.
- 该平台非常适合推进心脏病研究和药物疗效研究.
- CardioMEA 增强了 iPSC-CMs 在临床前电生理学中的实用性.
相关概念视频
01:12Analysis of Population Pharmacokinetic Data
235
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
235
01:11Genome-wide Association Studies-GWAS
12.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.5K
01:12Statistical Software for Data Analysis and Clinical Trials
498
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
498
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
2.1K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.1K
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
49
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
49